Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with O / Oxybutynin

Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination, by decreasing muscle spasms of the bladder. It competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor.
Ditropan Xl
CategoriesMuscarinic Antagonists
Anticholinergic Agents
Genitourinary Smooth Muscle Relaxants
ManufacturersWatson laboratories inc
Ortho mcneil janssen pharmaceuticals inc
Mikart inc
Novex pharma
Pharmaceutical assoc inc div beach products
Silarx pharmaceuticals inc
Vintage pharmaceuticals inc
Wockhardt eu operations (swiss) ag
Impax pharmaceuticals
Mylan pharmaceuticals inc
Osmotica pharmaceutical corp
Pliva inc
Quantum pharmics ltd
Usl pharma inc
Janssen Pharmaceuticals, Inc
PackagersAlza Corp.
Atlantic Biologicals Corporation
Cardinal Health
Dept Health Central Pharmacy
Dispensing Solutions
Global Pharmaceuticals
Goldline Laboratories Inc.
Impax Laboratories Inc.
Janssen-Ortho Inc.
Liberty Pharmaceuticals
Major Pharmaceuticals
McNeil Laboratories
Medisca Inc.
Murfreesboro Pharmaceutical Nursing Supply
Ortho Mcneil Janssen Pharmaceutical Inc.
Physicians Total Care Inc.
Pliva Inc.
Redpharm Drug
Remedy Repack
Resource Optimization and Innovation LLC
Schwarz Pharma Inc.
Teva Pharmaceutical Industries Ltd.
UDL Laboratories
USL Pharma Inc.
Vangard Labs Inc.
Vintage Pharmaceuticals Inc.
Watson Pharmaceuticals
SynonymsOxibutinina [INN-Spanish]
Oxybutynin Base
Oxybutynin Chloride
Oxybutynin Hydrochloride
oxybutynin topical gel
Oxybutynine [INN-French]
Oxybutyninum [INN-Latin]
transdermal patch


For the treatment of overactive bladder.


Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer.

mechanism of action

Oxybutynin exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. No blocking effects occur at skeletal neuromuscular junctions or autonomic ganglia (antinicotinic effects). By inhibiting particularily the M1 and M2 receptors of the bladder, detrusor activity is markedly decreased.


LD50=1220 mg/kg (Orally in rats, Goldenthal)


Hepatic, primarily by CYP3A4


Rapidly absorbed from gastrointestinal tract.

half life

12.4-13.2 hours

route of elimination

Oxybutynin is metabolized primarily by the cytochrome P450 enzyme systems, particularly CYP3A4, found mostly in the liver and gut wall. Oxybutynin is extensively metabolized by the liver, with less than 0.1% of the administered dose excreted unchanged in the urine. Also, less than 0.1% of the administered dose is excreted as the metabolite N-desethyloxybutynin.

drug interactions

Carbamazepine: Oxybutynin may cause carbamazepine toxicity

Donepezil: Possible antagonism of action

Galantamine: Possible antagonism of action

Rivastigmine: Possible antagonism of action

Tacrine: The therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Oxybutynin, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents.

Trimethobenzamide: Trimethobenzamide and Oxybutynin, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.

Triprolidine: Triprolidine and Oxybutynin, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.

Trospium: Trospium and Oxybutynin, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects.